U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Name Type Language
Imapextide
INN  
Official Name English
9-29-Glucagon-like peptide I [9-[N-(17-carboxy-1-oxoheptadecyl)-L-aspartic acid],16-glutamic acid,19-valine,20-arginine,28-arginine] (human) fusion protein with 30-39-exendin-4 (human)
Preferred Name English
glucagon-like peptide 1(15-35) [human GLP-1(15-35)] (1-21 in the real sequence), [G<sup>22</sup>>E<sup>8</sup>, A<sup>25</sup>>V<sup>11</sup>, K<sup>26</sup>>R<sup>12</sup>, K<sup>34</sup>>R<sup>20</sup>]-variant, fused to the C-terminal (30-39)-peptide
Common Name English
N-(17-carboxyheptadecanoyl)-L-?-aspartyl-L-valyl-L-seryl-L-seryl-Ltyrosyl-L-leucyl-L-?-glutamyl-L-?-glutamyl-L-glutaminyl-L-alanyl-Lvalyl-L-arginyl-L-?-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-Ltryptophyl-L-leucyl-L-valyl-L-arginylglycylglycyl-L-prol
Common Name English
imapextide [INN]
Common Name English
Code System Code Type Description
INN
13532
Created by admin on Wed Apr 02 17:18:44 GMT 2025 , Edited by admin on Wed Apr 02 17:18:44 GMT 2025
PRIMARY
FDA UNII
E8L272T7FX
Created by admin on Wed Apr 02 17:18:44 GMT 2025 , Edited by admin on Wed Apr 02 17:18:44 GMT 2025
PRIMARY
CAS
3004569-93-8
Created by admin on Wed Apr 02 17:18:44 GMT 2025 , Edited by admin on Wed Apr 02 17:18:44 GMT 2025
PRIMARY